Washington, DC, United States of America

Marshall Lynn Summar

This inventor holds 21 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 11 EPO patents. Top assignees: Vanderbilt University, Children's National Medical Center, University System of Maryland. Active years: 2002-2026.

USPTO Granted Patents = 21 (Patent Applications = 8)

% Patents Active = 81.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 8)

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 166(Granted Patents)

Location History:

Brentwood, TN (US) (2002 - 2018)
Washington, DC (US) (2016 - 2024)
Kansas City, KS (US) (2024)

Company Filing History:

12 out of 1,218

Vanderbilt University

patents

8 out of 84

Children's National Medical Center

patents

4 out of 2,022

University System of Maryland

patents

4. 2 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

5. 2 out of 158

The University of Mississippi

patents

6. 1 out of 2

Asklepion Pharmaceuticals, LLC

patents

7. 1 out of 896

Cerner Innovation, Inc.

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12540348 - DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF AMINOACIDOPATHIES (2026-02-03),

2. 12329732 - Citrulline for treatment of sickle cell crisis (2025-06-17),

3. 12087400 - Genomic variant re-classification (2024-09-10),

4. 12064409 - Action of L-citrulline to prevent or treat endothelial dysfunction (2024-08-20),

5. 11351135 - Citrulline for treatment of sickle cell crisis (2022-06-07),

6. 10792339 - Methods and compositions for treating phenylketonuria (2020-10-06),

7. 10620187 - Device and methods of using device for detection of hyperammonemia (2020-04-14),

8. 10591495 - Device and methods of using device for detection of hyperammonemia (2020-03-17),

9. 10525026 - Intravenous administration of citrulline during surgery (2020-01-07),

10. 10500181 - Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage (2019-12-10),

11. 10392646 - Device and methods of using device for detection of aminoacidopathies (2019-08-27),

12. 10265286 - Sequelae of cardiopulmonary bypass-induced pulmonary injury (2019-04-23),

13. 10204260 - Device and method for classifying a condition based on image analysis (2019-02-12),

14. 9952199 - Device and methods of using device for detection of hyperammonemia (2018-04-24),

15. 9943494 - Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage (2018-04-17),

Title: The Innovative Journey of Marshall Lynn Summar

Introduction: Marshall Lynn Summar, a pioneering inventor based in Washington, DC, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Marshall Lynn Summar holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, Marshall Lynn Summar has established himself as a leading figure in the innovation landscape. His work has not only revolutionized industries but has also inspired a new generation of inventors.

Collaborations: Throughout his career, Marshall Lynn Summar has collaborated with top research institutions, leading companies, and brilliant minds in the field of technology. These collaborations have resulted in cutting-edge inventions that have pushed the boundaries of what is possible.

Conclusion: Marshall Lynn Summar's passion for innovation, coupled with his relentless drive to create, has solidified his position as a trailblazer in the world of inventions. His work continues to impact industries and pave the way for a future where technology knows no bounds.